Trinity Biotech (TRIB) Projected to Post Quarterly Earnings on Thursday

Trinity Biotech (NASDAQ:TRIB) is projected to release its earnings data before the market opens on Thursday, April 3rd. Analysts expect Trinity Biotech to post earnings of ($0.30) per share for the quarter.

Trinity Biotech Stock Performance

NASDAQ TRIB opened at $0.57 on Wednesday. The business has a fifty day simple moving average of $0.77 and a 200 day simple moving average of $1.08. Trinity Biotech has a 12 month low of $0.56 and a 12 month high of $3.55. The firm has a market capitalization of $10.29 million, a P/E ratio of -0.25 and a beta of 1.20.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Trinity Biotech in a report on Sunday. They issued a “sell” rating for the company.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.